svg-arrow-next svg-arrow-prev
×

Order online: 0917-565-3700/ 0998-530-3700

0
Checkout
Toggle menu
Wish List
Gift Certificates
cart icon
0
My Cart
cart icon
0
sidebar
Nexium 40mg 1 Tablet

Nexium 40mg 1 Tablet

(No reviews) Write a Review
₱154.50
  per tablet

SKU:
002476
Generic Name:
Esomeprazole


Note: Uploaded prescription slip is subject to validation by our Pharmacist.

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

Nexium 40mg 1 Tablet

₱154.50
Choose Option

Nexium 40mg 1 Tablet

₱154.50

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

✕

Description

Hide Reviews Show Reviews

IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.

An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.

Brand Name NEXIUM 40MG
Generic Name Esomeprazole (as Magnesium Trihydrate)
Strength 40mg Enteric coated tablet
Dosage Form Tablet
Class Name Proton pump inhibitor
Indication/Usage

Esomeprazole (NEXIUM) tablets are indicated for:
Gastroesophageal Reflux Disease (GERD)
- treatment of erosive reflux esophagitis
- long-term management of patients with healed esophagitis to prevent relapse
- symptomatic treatment of gastroesophageal reflux disease (GERD)
Patients requiring continued non-steroidal anti-inflammatory (NSAID) therapy
- treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug (NSAID) therapy
- healing of gastric ulcers associated with non-steroidal anti-inflammatory drug (NSAID) therapy, including COX-2 selective NSAIDs
- prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drug (NSAID) therapy, including COX-2 selective NSAIDs, in patients at risk
Patients requiring continued low dose aspirin (75-325 mg)
therapy
- prevention of gastric and/or duodenal ulcers associated with low dose aspirin therapy, in patients at risk

Following treatment with Esomeprazole (NEXIUM) IV:
Maintenance of hemostasis and prevention of rebleeding of gastric or duodenal ulcers In combination with an appropriate antibacterial therapeutic
regimen for the eradication of Helicobacter pylori and
- healing of Helicobacter pylori associated duodenal ulcer and
- prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers
Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion

Dosage and Administration

Adults
Gastroesophageal Reflux Disease (GERD)
- treatment of erosive reflux esophagitis
40 mg once daily for 4 weeks.
An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who
have persistent symptoms.
- long-term management of patients with healed esophagitis to prevent relapse
20 mg once daily.
- symptomatic treatment of GERD 20 mg once daily in patients without esophagitis. If symptom control has not been achieved after 4 weeks, the patient
should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on demand regimen taking 20 mg once daily, when needed. In NSAID treated risk patients subsequent symptom control using on demand treatment is not recommended.
Patients requiring continued non-steroidal anti-inflammatory (NSAID) therapy
- treatment of upper gastrointestinal symptoms associated with NSAID therapy
20 mg once daily in patients requiring NSAID therapy.

If symptom control has not been achieved after 4 weeks, the patient should be further investigated.
- healing of gastric ulcers associated with NSAID therapy:
20 mg or 40 mg once daily for 4 to 8 weeks
- prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk:
20 mg or 40 mg once daily
Patients requiring continued low dose aspirin therapy
- prevention of gastric and/or duodenal ulcers associated with low dose aspirin therapy in patients at risk:
20 mg or 40 mg once daily
Maintenance of hemostasis and prevention of rebleeding of gastric or duodenal ulcers following treatment with Esomeprazole (NEXIUM) IV
40 mg once daily for 4 weeks. The oral treatment period should be preceded by acid-suppression therapy with Esomeprazole
(NEXIUM) IV 80 mg administered as bolus infusion over 30 minutes followed by a continuous intravenous infusion of 8 mg/hr given over 3 days

In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and
- healing of Helicobacter pylori associated duodenal ulcer and prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers 20 mg Esomeprazole (NEXIUM) with 1 g amoxicillin and 500 mg clarithromycin, all twice daily for 7 days.

Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion
The recommended initial dosage is Esomeprazole (NEXIUM) 40 mg twice daily. The dosage should then be individually adjusted and treatment continued as long as clinically indicated. Doses up to 120 mg twice daily have been administered.

Children 12 – 18 years
Gastroesophageal Reflux Disease (GERD)
- treatment of erosive reflux esophagitis
40 mg once daily for 4 weeks.
An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who have persistent symptoms.
- long-term management of patients with healed esophagitis to prevent relapse
20 mg once daily
- symptomatic treatment of gastroesophageal reflux disease (GERD)
20 mg once daily in patients without esophagitis. If symptom control has not been achieved after 4 weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using 20 mg once daily under medical supervision.
Treatment of duodenal ulcer caused by H. Pylori
When selecting appropriate combination therapy, consideration should be given to official national, regional and local guidance regarding bacterial resistance, duration of treatment (most commonly 7 days but sometimes up to 14 days), and appropriate use of antibacterial agents.
The treatment should be supervised by a specialist.
The dosage recommendation for esomeprazole is the following:
20 mg twice daily for one week

Children 1 – 11 years
Gastroesophageal Reflux Disease (GERD)
- treatment of erosive reflux esophagitis
Weight <20 kg: 10 mg once daily for 8 weeks.
Weight ≥20 kg: 10 mg or 20 mg once daily for 8 weeks.
- long-term management of patients with healed esophagitis to prevent relapse
10 mg once daily
- symptomatic treatment of gastroesophageal reflux disease (GERD)
10 mg once daily for up to 8 weeks.
Doses over 1 mg/kg/day have not been studied.

Children 0 – 1 year
Gastroesophageal Reflux Disease (GERD)
Treatment of gastroesophageal reflux disease (GERD) diagnostically confirmed through pH probe or endoscopy

1 – 11 months
Weight 3 kg to 5 kg: 2.5 mg once daily for up to 6 weeks
Weight > 5 kg to 7.5 kg: 5 mg once daily for up to 6 weeks
Weight >7.5 kg to 12 kg: 10 mg once daily for up to 6 weeks
Doses over 1.33 mg/kg/day have not been studied.

0 – 1 month
Weight > 2.5 kg: 2.5 mg once daily for up to 4 weeks
Impaired renal function
Dose adjustment is not required in patients with impaired renal function. Due to limited experience in patients with severe renal insufficiency, such patients should be treated with caution.
Impaired hepatic function
Dose adjustment is not required in patients with mild to moderate liver impairment. For patients with severe liver impairment, a maximum daily dose of 20 mg Esomeprazole (NEXIUM) should not be exceeded.

Elderly
Dose adjustment is not required in the elderly.
Warning and Precautions This medicinal product contains sucrose and
glucose. Patients with rare hereditary problems
of fructose intolerance, glucose-galactose
malabsorption or sucrase-isomaltase insufficiency
should not take this medicine.
Contraindication Known hypersensitivity to esomeprazole, substituted benzimidazoles or any other constituents of the formulation.
Requires prescription? Yes
Storage Conditions Store at temperatures not exceeding 30°C, away from direct heat and sunlight
Manufacturer AstraZeneca AB
Regulatory Classification Prescription Drug

Related Products

Be a member